Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profusa (PFSA) Notes Payables (2023 - 2025)

Profusa filings provide 3 years of Notes Payables readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Notes Payables rose 47.91% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 47.91% increase, with the full-year FY2025 number at $1.3 million, up 47.91% from a year prior.
  • Notes Payables hit $1.3 million in Q4 2025 for Profusa, up from $1.0 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $1.9 million in Q2 2025 to a low of $23487.0 in Q1 2025.
  • Median Notes Payables over the past 3 years was $1.3 million (2024), compared with a mean of $1.2 million.
  • The widest YoY moves for Notes Payables: up 47.91% in 2025, down 98.14% in 2025.
  • Profusa's Notes Payables stood at $944118.0 in 2023, then dropped by 3.61% to $910000.0 in 2024, then soared by 47.91% to $1.3 million in 2025.
  • The last three reported values for Notes Payables were $1.3 million (Q4 2025), $1.0 million (Q3 2025), and $1.9 million (Q2 2025) per Business Quant data.